Share Email Print

Proceedings Paper

Detection of early bladder carcinoma by fluorescence cystoscopy with Hexvix: optical characterization of a high magnification cystoscope
Author(s): Blaise Lovisa; Patrice Jichlinski; Daniela Aymon; Bernd-Claus Weber; Hubert van den Bergh; Georges Wagnières
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Fluorescence detection of early superficial bladder cancer has been well established over the last years. This technique exploits the selective production and accumulation within cancerous tissues of photoactive porphyrins (PaP), mainly protoporphyrin IX (PpIX), after the instillation of hexaminolevulinic acid (Hexvix®) in the bladder. Although the selective production of PpIX and the sensitivity of this procedure are outstanding, its specificity can be improved due to false positive (FP) lesions. Therefore, our current research focuses on the Characterization of positive sites by high magnification cystoscopy. Cancerization process often combines with changes in vascular architecture. It is likely that the visualization of these modifications should allow us to differentiate false and true positive (TP). New methods, using high magnification (HM) endoscopy, are being investigated by our group, and hopefully resulting in a reduced number of biopsies. In this study, we are using a dedicated rigid cystoscope, allowing conventional magnification during "macroscopic" white light and fluorescence observation, as well as image acquisition with HM when the endoscope is in contact with the tissue. This is realized by an optical setup directly integrated in the cystoscope. We describe here an offclinics calibration procedure that will allow us to quantify the vessel structure and size once we use this optics to observe the bladder mucosa.

Paper Details

Date Published: 23 February 2009
PDF: 6 pages
Proc. SPIE 7161, Photonic Therapeutics and Diagnostics V, 716118 (23 February 2009); doi: 10.1117/12.809195
Show Author Affiliations
Blaise Lovisa, Swiss Federal Institute of Technology (Switzerland)
Patrice Jichlinski, CHUV Univ. Hospital (Switzerland)
Daniela Aymon, CHUV Univ. Hospital (Switzerland)
Bernd-Claus Weber, Richard Wolf GmbH (Switzerland)
Hubert van den Bergh, Swiss Federal Institute of Technology (Switzerland)
Georges Wagnières, Swiss Federal Institute of Technology (Switzerland)

Published in SPIE Proceedings Vol. 7161:
Photonic Therapeutics and Diagnostics V
Henry Hirschberg; Brian Jet-Fei Wong; Kenton W. Gregory; Reza S. Malek; Nikiforos Kollias; Bernard Choi; Guillermo J. Tearney; Justus F. R. Ilgner; Steen J. Madsen; Laura Marcu; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top